Search research articles
Contact Us
Filters
Showing results (611-620 of 622) with videos related to
Page
of 63
Sort By:
Scientific Reports
|
January 27, 2023
African coastal camera network efforts at monitoring ocean, climate, and human impacts
G O Abessolo, R Almar, D B Angnuureng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 16, 2022
Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial
B Lian, L Si, Z H Chi, et al.
Cancer Biomarkers : Section a of Disease Markers
|
April 10, 2018
Diagnostic and prognostic implications of serum miR-101 in osteosarcoma
Z-S Yao, C Li, D Liang, et al.
Science (New York, N.Y.)
|
June 20, 1998
Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa
J D Eudy, M D Weston, S Yao, et al.
Lupus
|
June 3, 2010
TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population
C-F He, Y-S Liu, Y-L Cheng, et al.
The Pharmacogenomics Journal
|
September 4, 2013
Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer
S Yao, L E Sucheston, H Zhao, et al.
Thorax
|
June 22, 2016
Latrophilin receptors: novel bronchodilator targets in asthma
A Faiz, C Donovan, M Ae Nieuwenhuis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 26, 2019
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
F Wang, X L Wei, F H Wang, et al.
Leukemia
|
February 14, 2018
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
M -L Nairismägi, M E Gerritsen, Z M Li, et al.
Journal of Hepatology
|
March 27, 2023
Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis
Ang Cui, Bo Li, Michael S Wallace, et al.
Page
of 63
Search research articles
Search
Showing results (611-620 of 622) with videos related to
Sort By:
Page
of 63
Scientific Reports
|
January 27, 2023
African coastal camera network efforts at monitoring ocean, climate, and human impacts
G O Abessolo, R Almar, D B Angnuureng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 16, 2022
Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial
B Lian, L Si, Z H Chi, et al.
Cancer Biomarkers : Section a of Disease Markers
|
April 10, 2018
Diagnostic and prognostic implications of serum miR-101 in osteosarcoma
Z-S Yao, C Li, D Liang, et al.
Science (New York, N.Y.)
|
June 20, 1998
Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa
J D Eudy, M D Weston, S Yao, et al.
Lupus
|
June 3, 2010
TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population
C-F He, Y-S Liu, Y-L Cheng, et al.
The Pharmacogenomics Journal
|
September 4, 2013
Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer
S Yao, L E Sucheston, H Zhao, et al.
Thorax
|
June 22, 2016
Latrophilin receptors: novel bronchodilator targets in asthma
A Faiz, C Donovan, M Ae Nieuwenhuis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 26, 2019
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
F Wang, X L Wei, F H Wang, et al.
Leukemia
|
February 14, 2018
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
M -L Nairismägi, M E Gerritsen, Z M Li, et al.
Journal of Hepatology
|
March 27, 2023
Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis
Ang Cui, Bo Li, Michael S Wallace, et al.
Page
of 63